Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of October 2017. The report focuses on a legal development regarding a lawsuit filed against the Company in June 2015.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The only financial figure disclosed is a court-awarded payment of NIS 50,000 to cover legal expenses.
Material Changes
On October 26, 2017, the claimant in the June 2015 lawsuit filed a petition with the Supreme Court appealing a July 18, 2017, District Court ruling. The District Court had previously denied the request to recognize the lawsuit as a class action and awarded the Company NIS 50,000 for expenses.
Outlook, Risks, and Management Commentary
Management believes that the District Court's ruling is not likely to be overturned by the Supreme Court. The primary risk identified is the potential appeal of the favorable District Court decision regarding the class action status of the 2015 lawsuit.
Investor Verification Points
- Verify the status of the Supreme Court appeal filed on October 26, 2017.
- Confirm the finality of the NIS 50,000 expense award from the District Court.
- Monitor for any future filings regarding the outcome of the Supreme Court petition.